Target- |
Mechanism- |
Active Org.- |
Originator Org.- |
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
葆泽胶囊治疗黄褐斑(肝郁肾虚、气滞血瘀证)随机、双盲、剂量平行对照、多中心Ⅱ期临床试验
[Translation] A randomized, double-blind, dose-controlled, multicenter phase II clinical trial of Baoze Capsule in the treatment of chloasma (liver depression and kidney deficiency, qi stagnation and blood stasis syndrome).
初步评价葆泽胶囊治疗黄褐斑(肝郁肾虚、气滞血瘀证)的有效性与安全性,同时进行剂量探索,为Ⅲ期临床试验提供依据。
[Translation] To preliminarily evaluate the effectiveness and safety of Baoze Capsule in the treatment of chloasma (liver depression and kidney deficiency, qi stagnation and blood stasis syndrome), and conduct dose exploration to provide a basis for Phase III clinical trials.
100 Clinical Results associated with Beijing Kangtaijian Pharmaceutical Research Institute
0 Patents (Medical) associated with Beijing Kangtaijian Pharmaceutical Research Institute
100 Deals associated with Beijing Kangtaijian Pharmaceutical Research Institute
100 Translational Medicine associated with Beijing Kangtaijian Pharmaceutical Research Institute